The Peripheral Immune Landscape in a Patient with Myocarditis after the Administration of BNT162b2 mRNA Vaccine

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has posed a serious threat to global public health. A novel vaccine made from messenger RNA (mRNA) has been developed and approved for use at an unprecedented pace. However, an increased risk of myocarditis has been reported a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Bo Kyung, Oh, Tae Gyu, Bu, Seonghyeon, Seo, Kyung Jin, Kwon, Se Hwan, Lee, Ji Yoon, Kim, Yeumin, Kim, Jae-woo, Ahn, Hyo-Suk, Fang, Sungsoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Molecular and Cellular Biology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589374/
https://www.ncbi.nlm.nih.gov/pubmed/35904026
http://dx.doi.org/10.14348/molcells.2022.0031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589374/
https://www.ncbi.nlm.nih.gov/pubmed/35904026
http://dx.doi.org/10.14348/molcells.2022.0031

Ejemplares similares